Overview

Combination Facial Aesthetic Treatment in Millennials

Status:
Completed
Trial end date:
2021-05-19
Target enrollment:
Participant gender:
Summary
With 63% of consumers willing to consider investing in facial aesthetics and 73% of consumers worldwide expecting to invest in aesthetic treatments in the upcoming year, it is imperative to explore patient satisfaction and psychosocial impact of a multimodal aesthetic treatment in a millennial cohort. The investigators hypothesize that a combination approach to facial aesthetic treatment in a millennial cohort will result in increased patient-reported satisfaction in multiple areas, including perception of aging concerns and quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
State University of New York - Downstate Medical Center
Collaborator:
Allergan Sales, LLC
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A